Holen Sie sich die Stockscreener-App
14.79
3.79%
0.54
Handel nachbörslich:
14.79
Schlusskurs vom Vortag:
$14.25
Offen:
$14.48
24-Stunden-Volumen:
524.43K
Relative Volume:
1.11
Marktkapitalisierung:
$1.38B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
-32.53%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$14.15
$15.27
1-Wochen-Bereich:
$13.94
$15.27
52-Wochen-Spanne:
$13.75
$27.00
Kardigan Inc Stock (KARD) Company Profile
Compare KARD vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KARD
Kardigan Inc
|
14.79 | 1.38B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 127.93B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Kardigan Inc Aktie (KARD) Neueste Nachrichten
Kardigan Appoints Google Finance Executive Kristin Reinke to Board of Directors - citybiz
Kardigan Adds Google Finance Executive to Board Leadership - TipRanks
Kardigan, Inc. (KARD) stock price, news, quote and history - uk.finance.yahoo.com
Kardigan appoints Kristin Reinke to board of directors - Investing.com
Kardigan Announces Appointment of Kristin Reinke to its Board of Directors - Business Wire
Kardigan (KARD) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
Kardigan, Inc.(NasdaqGM: KARD) added to S&P TMI Index - marketscreener.com
Kardigan (NASDAQ:KARD) Is In A Good Position To Deliver On Growth Plans - webull.com
Companies Like Kardigan (NASDAQ:KARD) Are In A Position To Invest In Growth - Moomoo
Kardigan, Inc.(NasdaqGM: KARD) added to Russell 2000 Dynamic Index - marketscreener.com
Kardigan (KARD) Stock Price, News & Analysis - Stock Titan
Kardigan: Funded Precision Cardiology Offers More Than Pipeline Diversification - Seeking Alpha
Kardigan’s Tonlamarsen Trial Targets Severe Hypertension: What Investors Should Watch - TipRanks
Kardigan at Cantor conference: platform bet on heart drugs - Investing.com
Kardigan at Cantor conference: platform bet on heart drugs By Investing.com - Investing.com Canada
KARDKardigan Inc Short Interest - Finviz
KARD Should I Buy - Intellectia AI
Kardigan to Present at Two September Investor Conferences - Yahoo Finance
Kardigan’s Danicamtiv Heart Study Moves Forward, Keeping KARD on Investors’ Radar - TipRanks
Kardigan (NASDAQ:KARD) Price Target Cut to $46.00 by Analysts at JPMorgan Chase & Co. - marketbeat.com
Will KARD be a Portfolio Killer in August? - Zacks Investment Research
Inside cardiovascular biotech Kardigan’s June IPO - CFO Brew
Kardigan Q2 Results: EPS misses estimates by 549.3% - scanx.trade
Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates - BioSpace
Kardigan Inc. Announces Q2 2026 Financial Results and Clinical Trial Updates - Kalkine Media
Kardigan Q2 Per-Share Loss Narrows - marketscreener.com
Kardigan, Inc. 2Q 2026: Net loss $116.2M, EPS $(4.61) — 10-Q Summary - TradingView
Earnings Flash (KARD) Kardigan Posts Q2 Loss $4.61 a Share - marketscreener.com
Kardigan: Q2 Earnings Snapshot - AOL.com
Kardigan, Inc. (NASDAQ:KARD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Kardigan reports Q2 2026 net loss $116.2M, cash $660.7M after IPO - TradingView
Kardigan Ord Shs (KARD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Kardigan (KARD) Institutional Ownership 2026 $KARD - marketbeat.com
KARD: NADetailed Earnings Estimates - Zacks Investment Research
KARD|Kardigan Ord Shs|Price:21.150|Chg%:+0.410 - TradingKey
Kardigan, Inc. Revenue Breakdown – NASDAQ:KARD - TradingView
Latest KARD ETF News Today | Earnings, Events & Price Alerts - Intellectia AI
Price to earnings ratio of Kardigan, Inc. – NASDAQ:KARD - TradingView
Price to earnings ratio of Kardigan, Inc. – BOATS:KARD - TradingView
Kardigan, Inc. (NASDAQ:KARD) Short Interest Up ∞ in June - MarketBeat
Hrtg Pv, L.p. Net Worth (2026) - GuruFocus
Kevin Anthony Kelly Net Worth (2026) - GuruFocus
Schf Cif 2024, L.p. Net Worth (2026) - GuruFocus
Keith Bryon Johnson Net Worth (2026) - GuruFocus
Kardigan, Inc.: Target Price Consensus and Analysts Recommendations | KARD | US4859251013 - marketscreener.com
Kardigan, Inc.: Revenue and Earnings Analysts Forecasts Revisions | KARD | US4859251013 - marketscreener.com
A Quick Look at Today's Ratings for Kardigan(KARD.US), With a Forecast Between $37 to $51 - Moomoo
Kardigan (KARD) grants 20,706 RSUs tied to Perceptive-linked director pay - Stock Titan
KARD Initiated Coverage by TD Cowen -- Price Target Announced at $46 - GuruFocus
KARD News & Events - Intellectia AI
TD Cowen initiates Kardigan stock with buy rating on cardiology pipeline - Investing.com UK
Finanzdaten der Kardigan Inc-Aktie (KARD)
Es liegen keine Finanzdaten für Kardigan Inc (KARD) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Kardigan Inc-Aktie (KARD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BERNS PAUL L | Director |
Jun 22 '26 |
Buy |
16.00 |
1,250,000 |
20,000,000 |
15,042,035 |
| ARCH Venture Partners XIII, LL | Director |
Jun 22 '26 |
Buy |
16.00 |
1,250,000 |
20,000,000 |
15,042,035 |
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):